骨关节炎
疾病
医学
重症监护医学
临床表型
人口
生物信息学
物理疗法
病理
替代医学
表型
生物化学
生物
环境卫生
基因
化学
作者
J. W. J. Bijlsma,Francis Bérenbaum,Floris P. J. G. Lafeber
出处
期刊:The Lancet
[Elsevier]
日期:2011-06-01
卷期号:377 (9783): 2115-2126
被引量:2012
标识
DOI:10.1016/s0140-6736(11)60243-2
摘要
Summary
Osteoarthritis is thought to be the most prevalent chronic joint disease. The incidence of osteoarthritis is rising because of the ageing population and the epidemic of obesity. Pain and loss of function are the main clinical features that lead to treatment, including non-pharmacological, pharmacological, and surgical approaches. Clinicians recognise that the diagnosis of osteoarthritis is established late in the disease process, maybe too late to expect much help from disease-modifying drugs. Despite efforts over the past decades to develop markers of disease, still-imaging procedures and biochemical marker analyses need to be improved and possibly extended with more specific and sensitive methods to reliably describe disease processes, to diagnose the disease at an early stage, to classify patients according to their prognosis, and to follow the course of disease and treatment effectiveness. In the coming years, a better definition of osteoarthritis is expected by delineating different phenotypes of the disease. Treatment targeted more specifically at these phenotypes might lead to improved outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI